FOXP3 and systemic sclerosis: Upon removing FoxP3+IL-17+ cells from the CD4+CD25+FoxP3+cell population, we further confirmed that there was no difference in the CD4+CD25+FoxP3+IL-17− cell population between SSc patients and healthy individuals, which also confirmed our hypothesis.